Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

Laboratory Report

Patient
Name: Rémy, Yves
DOB: 16-MAY-1948 (Age: 77)
Gender: male
Address:
rue de Turpin
06400 Cannes (France)
ID: 4543-821530-8 (ECI)
Report
Date: 13-AUG-2017
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Clinique du Méridien
06150 Cannes (France)
Specimen
Collected: 13-AUG-2017

Chemistry

Test 13-AUG-2017 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.2 H 4.0 - 5.6 %
Glucose [Mass/volume] in Blood 73.5 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 18.0 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.0 0.7 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.7 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 143.8 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.0 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 106.4 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.9 L 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 221.2 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 115.3 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 141.7 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 56.4 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated HbA1c, indicating impaired glucose control or possible diabetes, and high total and LDL cholesterol, suggesting increased cardiovascular risk. Carbon dioxide is slightly low, which may reflect mild metabolic acidosis or respiratory compensation. Renal function, electrolytes, and triglycerides are within normal limits. Recommend further evaluation and management of glycemic control and dyslipidemia.